136 related articles for article (PubMed ID: 32053085)
61. Design and evaluation of galactosylated chitosan/graphene oxide nanoparticles as a drug delivery system.
Wang C; Zhang Z; Chen B; Gu L; Li Y; Yu S
J Colloid Interface Sci; 2018 Apr; 516():332-341. PubMed ID: 29408121
[TBL] [Abstract][Full Text] [Related]
62. Functionalized MoS
Zhang X; Wu J; Williams GR; Niu S; Qian Q; Zhu LM
Colloids Surf B Biointerfaces; 2019 Jan; 173():101-108. PubMed ID: 30273870
[TBL] [Abstract][Full Text] [Related]
63. Algerian Propolis Potentiates Doxorubicin Mediated Anticancer Effect Against Human Pancreatic PANC-1 Cancer Cell Line through Cell Cycle Arrest, Apoptosis Induction and P-Glycoprotein Inhibition.
Rouibah H; Kebsa W; Lahouel M; Zihlif M; Ahram M; Aburmeleih B; Mustafa E; Al-Ameer HJ
Anticancer Agents Med Chem; 2018; 18(3):375-387. PubMed ID: 29318976
[TBL] [Abstract][Full Text] [Related]
64. Reduced graphene oxide (rGO) hybridized hydrogel as a near-infrared (NIR)/pH dual-responsive platform for combined chemo-photothermal therapy.
Liu W; Zhang X; Zhou L; Shang L; Su Z
J Colloid Interface Sci; 2019 Feb; 536():160-170. PubMed ID: 30366181
[TBL] [Abstract][Full Text] [Related]
65. Heterodimers made of metal-organic frameworks and upconversion nanoparticles for bioimaging and pH-responsive dual-drug delivery.
Ling D; Li H; Xi W; Wang Z; Bednarkiewicz A; Dibaba ST; Shi L; Sun L
J Mater Chem B; 2020 Feb; 8(6):1316-1325. PubMed ID: 31970370
[TBL] [Abstract][Full Text] [Related]
66. Towards the development of multifunctional chitosan-based iron oxide nanoparticles: Optimization and modelling of doxorubicin release.
Soares PIP; Sousa AI; Ferreira IMM; Novo CMM; Borges JP
Carbohydr Polym; 2016 Nov; 153():212-221. PubMed ID: 27561489
[TBL] [Abstract][Full Text] [Related]
67. A reversible, switchable pH-driven quaternary ammonium pillar[5]arene nanogate for mesoporous silica nanoparticles.
Santos ECS; Dos Santos TC; Fernandes TS; Jorge FL; Nascimento V; Madriaga VGC; Cordeiro PS; Checca NR; Da Costa NM; Pinto LFR; Ronconi CM
J Mater Chem B; 2020 Jan; 8(4):703-714. PubMed ID: 31867589
[TBL] [Abstract][Full Text] [Related]
68. Tumor-preferential sustained drug release enhances antitumor activity of block copolymer micelles.
Ponta A; Bae Y
J Drug Target; 2014 Aug; 22(7):619-28. PubMed ID: 24766185
[TBL] [Abstract][Full Text] [Related]
69. A smart multifunctional nanocomposite for intracellular targeted drug delivery and self-release.
Wang C; Lv P; Wei W; Tao S; Hu T; Yang J; Meng C
Nanotechnology; 2011 Oct; 22(41):415101. PubMed ID: 21914934
[TBL] [Abstract][Full Text] [Related]
70. Collagen/chitosan film containing biotinylated glycol chitosan nanoparticles for localized drug delivery.
Chen MM; Huang YQ; Cao H; Liu Y; Guo H; Chen LS; Wang JH; Zhang QQ
Colloids Surf B Biointerfaces; 2015 Apr; 128():339-346. PubMed ID: 25784300
[TBL] [Abstract][Full Text] [Related]
71. Chitosan-tripolyphosphate nanoparticles functionalized with a pH-responsive amphiphile improved the in vitro antineoplastic effects of doxorubicin.
Nogueira-Librelotto DR; Scheeren LE; Vinardell MP; Mitjans M; Rolim CMB
Colloids Surf B Biointerfaces; 2016 Nov; 147():326-335. PubMed ID: 27543694
[TBL] [Abstract][Full Text] [Related]
72. Dual responsive magnetic composite nanogels for thermo-chemotherapy.
Indulekha S; Arunkumar P; Bahadur D; Srivastava R
Colloids Surf B Biointerfaces; 2017 Jul; 155():304-313. PubMed ID: 28448900
[TBL] [Abstract][Full Text] [Related]
73. α-Tocopherol succinate improves encapsulation and anticancer activity of doxorubicin loaded in solid lipid nanoparticles.
Oliveira MS; Mussi SV; Gomes DA; Yoshida MI; Frezard F; Carregal VM; Ferreira LAM
Colloids Surf B Biointerfaces; 2016 Apr; 140():246-253. PubMed ID: 26764108
[TBL] [Abstract][Full Text] [Related]
74. Enhanced cytotoxicity of core modified chitosan based polymeric micelles for doxorubicin delivery.
Ye YQ; Chen FY; Wu QA; Hu FQ; Du YZ; Yuan H; Yu HY
J Pharm Sci; 2009 Feb; 98(2):704-12. PubMed ID: 18563810
[TBL] [Abstract][Full Text] [Related]
75. Stimuli-sensitive hollow spheres from chitosan-graft-β-cyclodextrin for controlled drug release.
Yu N; Li G; Gao Y; Liu X; Ma S
Int J Biol Macromol; 2016 Dec; 93(Pt A):971-977. PubMed ID: 27663551
[TBL] [Abstract][Full Text] [Related]
76. Multi-stimuli responsive mesoporous silica-coated carbon nanoparticles for chemo-photothermal therapy of tumor.
Lu H; Zhao Q; Wang X; Mao Y; Chen C; Gao Y; Sun C; Wang S
Colloids Surf B Biointerfaces; 2020 Jun; 190():110941. PubMed ID: 32169778
[TBL] [Abstract][Full Text] [Related]
77. Heparin modified graphene oxide for pH-sensitive sustained release of doxorubicin hydrochloride.
Zhang B; Yang X; Wang Y; Zhai G
Mater Sci Eng C Mater Biol Appl; 2017 Jun; 75():198-206. PubMed ID: 28415455
[TBL] [Abstract][Full Text] [Related]
78. Targeted delivery and controlled release of doxorubicin to cancer cells by smart ATP-responsive Y-shaped DNA structure-capped mesoporous silica nanoparticles.
Bagheri E; Alibolandi M; Abnous K; Taghdisi SM; Ramezani M
J Mater Chem B; 2021 Feb; 9(5):1351-1363. PubMed ID: 33447840
[TBL] [Abstract][Full Text] [Related]
79. Light-responsive polymersomes with a charge-switch for targeted drug delivery.
Zhou Y; Chen R; Yang H; Bao C; Fan J; Wang C; Lin Q; Zhu L
J Mater Chem B; 2020 Jan; 8(4):727-735. PubMed ID: 31894822
[TBL] [Abstract][Full Text] [Related]
80. Synthesis and characterization of chitosan/carbon quantum dots/Fe
Zoghi M; Pourmadadi M; Yazdian F; Nigjeh MN; Rashedi H; Sahraeian R
Int J Biol Macromol; 2023 Sep; 249():125788. PubMed ID: 37437675
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
